Abbas, Qasir
Latif, Sana
Ayaz Habib, Hina
Shahzad, Salman
Sarwar, Uzma
Shahzadi, Mafia
Ramzan, Zoobia
Washdev, Washdev
Article History
Received: 1 August 2022
Accepted: 12 January 2023
First Online: 3 February 2023
Declarations
:
: The study protocol was approved by the Institutional Review Board (IRB), Government College University, and Faisalabad, Pakistan (i.e., Ref.No. GCUF/ERC/2270). Furthermore, the protocol was also registered and approved by the Thai Clinical Trial Registry (i.e., TCTR20210703002 on 03 July, 2021, with URL:ExternalRef removed). Moreover, informed consent was obtained from all the participants. Participants who read and then signed the consent form were enrolled in the study. All procedures including participant enrollment, screening, data collection, data scrutiny and analysis were performed in accordance with relevant guidelines.
: Not applicable.
: The authors declare that they have no competing interests.